In our latest healthcare sector report we look at how Roche finally decided to take the plunge into genomic profiling with the final step in the Foundation Medicine investment. June was also an interesting month for cannabis-derived medicine with the first drug approved by the FDA and a big raise from the world-leading cannabis company, Canopy Growth Corporation.

Click here to download the report >>